Improved adeno-associated virus (AAV) serotype 1 and 5 vectors for gene therapyDwaipayan Sen(Manchester Academic Health Science Centre), Giridhara R. Jayandharan(Bio-Medical Science (South Korea))Scientific ReportsMay 13, 201310.1038/srep01832Cited by 43SaveCiteExport RISWatch citationsRelated PapersActivation of the Cellular Unfolded Protein Response by Recombinant Adeno-Associated Virus Vectors|PLoS ONE|2013|49Synergistic inhibition of PARP‐1 and NF‐κB signaling downregulates immune response against recombinant AAV2 vectors during hepatic gene therapy|European Journal of Immunology|2015|10